ArticleCancers2022

New Therapy Options for Neuroendocrine Carcinoma of the Pancreas-The Emergent Substance GP-2250 and Gemcitabine Prove to Be Highly Effective without the Development of Secondary Resistances In Vitro and In Vivo.

Marie Buchholz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.